This is supported by the finding that circulating IL-34 is significantly reduced in the HCC patients following transarterial chemoembolisation (TACE), which is minimally invasive but may cause the destruction of substantial numbers of HCC cells in the affected liver following the local intervention (40). Here, IL34 is linked to hepatocellular carcinoma.